NIVAGEN ZINC OXIDE
NDC 75834-170, zinc oxide, ointment, from Nivagen Pharmaceuticals, Inc..
- Product NDC
- 75834-170
- Status
- Listed
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75834-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZINC OXIDE200 mg/g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75834-170-01 | 75834017001 | 28.4 g in 1 TUBE (75834-170-01) |
| 75834-170-02 | 75834017002 | 56.7 g in 1 TUBE (75834-170-02) |
| 75834-170-15 | 75834017015 | 425 g in 1 JAR (75834-170-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 75834017001
GET /v1/drugs/nadac/75834017001NADAC price for package 75834017002
GET /v1/drugs/nadac/75834017002
Use it
Look up 75834-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75834-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75834-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.